Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

22-Dec-16 - 20-Dec-17
Buy Ratio:42%

Down

# Net Buyers:121
# Net Sellers:169

Previous 52 Weeks

24-Dec-15 - 21-Dec-16
Buy Ratio:42%
# Net Buyers:140
# Net Sellers:192
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
China Biologic Products, Inc.($14.63M)$1.53B  
Zoetis Inc.($4.30M)$787.76M  
Colucid Pharmaceuticals, Inc.$716.17M$720.43M  
Catalent, Inc.($13.81M)$607.33M  
Relypsa Inc--$140.73M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$716.17M$720.43M  
Acceleron Pharma Inc$20.95M$89.62M  
Akorn Inc$38.54M$52.65M  
Biogen Inc.$17.53M$38.17M  
Amicus Therapeutics Inc$19.69M$28.17M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.83B)($1.82B)  
Kite Pharma, Inc.($743.41M)($728.50M)  
Seattle Genetics Inc /wa($19.65M)($315.97M)  
Incyte Corp($47.29M)($289.73M)  
Vertex Pharmaceuticals Inc / Ma($219.48M)($180.12M)  
New Net Sellers
CompanyNet Buy AmountChange
Seattle Genetics Inc /wa($19.65M)($315.97M)  
Incyte Corp($47.29M)($289.73M)  
Acadia Pharmaceuticals Inc($15.08M)($169.91M)  
Abbott Laboratories($54.59M)($86.77M)  
Nexvet Biopharma Plc($76.62M)($78.18M)